Phibro Animal Health Corporation (NASDAQ:PAHC) Director Gerald K. Carlson sold 63,338 shares of the firm’s stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $33.31, for a total transaction of $2,109,788.78. Following the sale, the director now directly owns 50 shares of the company’s stock, valued at approximately $1,665.50. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Phibro Animal Health Corporation (PAHC) traded up 3.30% during midday trading on Friday, hitting $36.00. The stock had a trading volume of 371,077 shares. The firm has a 50 day moving average of $33.74 and a 200 day moving average of $29.57. The firm has a market cap of $1.43 billion, a price-to-earnings ratio of 22.36 and a beta of 1.35. Phibro Animal Health Corporation has a 52 week low of $17.96 and a 52 week high of $36.40.
Phibro Animal Health Corporation (NASDAQ:PAHC) last released its quarterly earnings data on Monday, May 8th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. Phibro Animal Health Corporation had a return on equity of 54.68% and a net margin of 8.49%. The company had revenue of $190 million for the quarter, compared to analysts’ expectations of $185.90 million. During the same period last year, the firm posted $0.38 earnings per share. Phibro Animal Health Corporation’s revenue was up 3.5% compared to the same quarter last year. Equities research analysts predict that Phibro Animal Health Corporation will post $1.45 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 22nd. Investors of record on Wednesday, May 31st will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Friday, May 26th. This represents a $0.40 annualized dividend and a dividend yield of 1.11%. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is presently 24.69%.
ILLEGAL ACTIVITY NOTICE: This news story was posted by Markets Daily and is the sole property of of Markets Daily. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.themarketsdaily.com/2017/06/16/phibro-animal-health-corp-pahc-director-sells-2109788-78-in-stock-updated-updated-updated.html.
Large investors have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. boosted its stake in Phibro Animal Health Corporation by 14.6% in the first quarter. Goldman Sachs Group Inc. now owns 64,096 shares of the company’s stock valued at $1,801,000 after buying an additional 8,157 shares during the period. Tudor Investment Corp ET AL boosted its stake in Phibro Animal Health Corporation by 66.2% in the first quarter. Tudor Investment Corp ET AL now owns 16,171 shares of the company’s stock valued at $454,000 after buying an additional 6,444 shares during the period. AQR Capital Management LLC increased its position in Phibro Animal Health Corporation by 50.4% in the first quarter. AQR Capital Management LLC now owns 78,343 shares of the company’s stock worth $2,201,000 after buying an additional 26,244 shares in the last quarter. Gotham Asset Management LLC purchased a new position in Phibro Animal Health Corporation during the first quarter worth $655,000. Finally, Highbridge Capital Management LLC purchased a new position in Phibro Animal Health Corporation during the first quarter worth $252,000. 47.60% of the stock is currently owned by institutional investors.
Several analysts recently issued reports on PAHC shares. BidaskClub downgraded shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday. Credit Suisse Group cut Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and raised their price objective for the company from $29.00 to $36.00 in a research note on Friday, June 2nd. Finally, Zacks Investment Research upgraded Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective on the stock in a research note on Thursday, May 11th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. Phibro Animal Health Corporation currently has an average rating of “Hold” and a consensus price target of $30.33.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.